Barry Simon

Dr. Simon served as ImmunityBio's President and CEO from 2007 to 2015, and is currently a Director and CCAO. Dr. Simon is also a Director and the Chairman of the Compensation Committee at Cue BioPharma and Viracta Therapeutics. Dr. Simon has worked at F. Hoffmann-La Roche, Roche Labs, Connetics Corp., Immunomedics, Immusol, NorthSound Capital, LLC, and HealthPro BioVentures as a Vice President, senior level, and advisory role. Dr. Simon has extensive expertise in both the public and private sectors, having led product and portfolio divestitures and acquisitions, strategic licensing and joint ventures, commercial product launches, IND & BLA regulatory submissions, and life cycle management. Dr. Simon worked in a variety of therapeutic areas, including cancer, virology, and dermatology, and on the introduction of eight medications. Dr. Simon completed corporate training programs at the London School of Business and Dartmouth College's Amos Tuck School of Business. Dr. Simon got his M.D. from the SUNY Downstate Health Sciences Center in New York and completed clinical training in Infectious Diseases, Anesthesiology, and Internal Medicine.

Barry Simon is the Director & Chief Corporate Affairs Officer at ImmunityBio, based in United States, North America. With a background in Health Care, Barry Simon has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.